© 2021 Thermo Fisher Scientific Inc. All rights reserved.
We offer a broad range of viral vector manufacturing platforms to support pre-clinical and human studies for viral vectors for gene and gene-modified cell therapies and vaccines.
| Pre-clinical | cGMP | |
|---|---|---|
| Suspension | 50L 200L | 50L 200L 4 x 200L 1000L |
| Adherent | Up to 48 flatstock vessels iCELLis® NANO iCELLis® 500 | Up to 48 flatstock vessels iCELLis® 500 |
Please contact us to learn more about our viral vector development and clinical services.
Download the “Leading Viral Vector CDMO Services for Cell and Gene Therapies” brochure to learn more about our end-to-end capabilities.